In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
about
The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin BImprovement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomesAspergillus fumigatus and aspergillosisClinical Translation of Nanomedicine.Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulationsTreatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans.Carrier effects on biological activity of amphotericin B.Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NFInfluence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.Liposomes in treatment of infectious diseases.Fusarium. A newly recognized fungal pathogen in immunosuppressed patients.Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis.Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion.Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis.Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice.Enhanced Killing and Antibiofilm Activity of Encapsulated Cinnamaldehyde against Candida albicans.
P2860
Q28322976-29B9FB39-4AE6-4847-B15A-9ADD5D0630C0Q28328605-B82DA318-8CE8-43D0-9BBE-A21B12B55CD4Q29617908-ED64FCB3-51F2-4148-9E55-472A8E096C26Q30355939-DB7D1E82-95A1-485F-ADE8-2D493545600CQ33693450-ED0BA8FC-318D-40AD-A049-05741FEAC292Q33749073-CF67BD1D-6214-4FCB-B866-603AF3B47F32Q35244089-CEB80ADC-7B12-4B84-AFCC-2F6A09843F58Q35372581-BBB0AB34-5544-49CF-A618-52235A0C327DQ35537748-1AF5AA7A-1141-4C3C-ACD0-FB735C6CBFBDQ35563027-BF3EA4A6-C305-4ED5-BA64-D08AAD4C4609Q35824054-3B09F966-E976-4484-A8B2-0ADA4F34E893Q36754865-ECD4F193-D81E-45ED-AD8F-16BCD491E95AQ36758184-25A9B82E-3B06-4440-81EE-0C305EAC23C9Q39663756-ED0F4C8B-FC41-4475-93A2-D4817B851BF1Q39719769-C5E2DB10-355D-4DEC-A663-EF0AFE510E0FQ39832102-C9263552-6B88-4F63-9100-5AECEBE32AE3Q39868009-6FBB272D-A3C2-4689-A3AA-19411987C26CQ40085689-E084FB12-86CD-4F25-902D-B91E2F2CA6EDQ40087802-01071E4F-DC8E-4813-BAD1-8C59C2133A86Q40655840-DBFE21FE-CE4F-46F8-86FC-5E931F2A5759Q40730943-3792A961-08E6-4D52-8651-CF92B5A7E914Q44423028-6125D0B9-79EC-4C60-AA94-849F2A45AEEEQ46361472-E6FC225C-EB96-45B5-BF42-9EDDAE1FF002Q47149925-B22163E9-39F4-4EEB-A8DE-07972008702E
P2860
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
In vitro antifungal activities ...... e-encapsulated amphotericin B.
@en
type
label
In vitro antifungal activities ...... e-encapsulated amphotericin B.
@en
prefLabel
In vitro antifungal activities ...... e-encapsulated amphotericin B.
@en
P2093
P356
P1476
In vitro antifungal activities ...... e-encapsulated amphotericin B.
@en
P2093
Fainstein V
Juliano RL
Lopez-Berestein G
P304
P356
10.1128/AAC.25.3.387
P407
P577
1984-03-01T00:00:00Z